检索结果 - Edward Arrowsmith

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma

    Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma 由 J. G. Berdeja, Lowell L. Hart, Joseph R. Mace, Edward Arrowsmith, James Essell, Rami Owera, John D. Hainsworth, Ian W. Flinn

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Phase II Study of Everolimus in Patients with Metastatic Colorectal Adenocarcinoma Previously Treated with Bevacizumab-, Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Based Regimens

    Phase II Study of Everolimus in Patients with Metastatic Colorectal Adenocarcinoma Previously Treated with Bevacizumab-, Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Based Regim... 由 Kimmie Ng, Josep Tabernero, Jimmy J. Hwang, Emilio Bajetta, Sunil Sharma, Salvatore A. Del Prete, Edward Arrowsmith, David P. Ryan, Michaela Šedová, Jin Jin, Kamel Malek, Charles S. Fuchs

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Safety and efficacy of nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma: results from the phase 3b/4 CheckMate 920 trial

    Safety and efficacy of nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma: results from the phase 3b/4 CheckMate 920 trial 由 Scott S. Tykodi, Lucio N. Gordan, Robert Alter, Edward Arrowsmith, Michael R. Harrison, Ivor Percent, Rakesh Singal, Peter J. Van Veldhuizen, Daniel J. George, Thomas E. Hutson, Joshua Zhang, Jesús Zoco, Jennifer L. Johansen, Arash Rezazadeh Kalebasty

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Phase 1 Expansion Cohort of Ramucirumab Plus Pembrolizumab in Advanced Treatment-Naive NSCLC

    Phase 1 Expansion Cohort of Ramucirumab Plus Pembrolizumab in Advanced Treatment-Naive NSCLC 由 Roy S. Herbst, Hendrik Tobias Arkenau, Johanna C. Bendell, Edward Arrowsmith, Martin Wermke, A. Segado Soriano, Nicolas Penel, Rafael Santana‐Davila, Helge Bischoff, Ian Chau, Gu Mi, Hong Wang, Erik Rasmussen, David Ferry, Bo H. Chao, Luis Paz‐Ares

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trial

    Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase... 由 Harry H. Yoon, Johanna C. Bendell, Fadi S. Braiteh, Irfan Firdaus, P. A. Philip, Allen Lee Cohn, Nancy Lewis, D. Mark Anderson, Edward Arrowsmith, Jonathan D. Schwartz, Ling Gao, Yanzhi Hsu, Yiwen Xu, D. Ferry, Steven R. Alberts, Zev A. Wainberg

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    A phase 2 study of AZD4635 in combination with durvalumab or oleclumab in patients with metastatic castration-resistant prostate cancer

    A phase 2 study of AZD4635 in combination with durvalumab or oleclumab in patients with metastatic castration-resistant prostate cancer 由 Gerald S. Falchook, James A. Reeves, Sunil Gandhi, David R. Spigel, Edward Arrowsmith, Daniel J. George, Janet L. Karlix, Gayle P. Pouliot, Maureen M. Hattersley, Eric T. Gangl, Gareth D. James, Jeff Thompson, Deanna L. Russell, Bhavickumar Patel, Rakesh Kumar, Emerson A. Lim

    出版 2024
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Phase 2, multicenter, open‐label study of tigatuzumab (CS‐1008), a humanized monoclonal antibody targeting death receptor 5, in combination with gemcitabine in chemotherapy‐naive patients with unresectable or metastatic pancreatic cancer

    Phase 2, multicenter, open‐label study of tigatuzumab (CS‐1008), a humanized monoclonal antibody targeting death receptor 5, in combination with gemcitabine in chemotherapy‐naive p... 由 Andres Forero‐Torres, Jeffrey R. Infante, David Waterhouse, Lucas Wong, Selwyn M. Vickers, Edward Arrowsmith, Aiwu Ruth He, Lowell L. Hart, David Trent, James L. Wade, Xiaoping Jin, Qiang Wang, TaShara Austin, Michael Rosen, Robert A. Beckman, Reinhard von Roemeling, Jonathan Greenberg, Mansoor N. Saleh

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Safety and efficacy of nivolumab plus ipilimumab in patients with advanced renal cell carcinoma with brain metastases: CheckMate 920

    Safety and efficacy of nivolumab plus ipilimumab in patients with advanced renal cell carcinoma with brain metastases: CheckMate 920 由 Hamid Emamekhoo, Mark R. Olsen, Bradley Curtis Carthon, Alexandra Drakaki, Ivor Percent, Ana M. Molina, Daniel C. Cho, Johanna C. Bendell, Lucio N. Gordan, Arash Rezazadeh Kalebasty, Daniel J. George, Thomas E. Hutson, Edward Arrowsmith, Joshua Zhang, Jesús Zoco, Jennifer L. Johansen, David Leung, Scott S. Tykodi

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Avelumab Plus Talazoparib in Patients With <i>BRCA1/2</i>- or <i>ATM</i>-Altered Advanced Solid Tumors

    Avelumab Plus Talazoparib in Patients With <i>BRCA1/2</i>- or <i>ATM</i>-Altered Advanced Solid Tumors 由 Alison M. Schram, Nicoletta Colombo, Edward Arrowsmith, Vivek Narayan, Kan Yonemori, Giovanni Scambia, Amelia Zelnak, Todd M. Bauer, Ning Jin, Susanna V. Ulahannan, Marco Colleoni, Philippe Aftimos, Mark T.A. Donoghue, Ezra Rosen, Vasilisa A. Rudneva, Melinda L. Telli, Susan M. Domchek, Matthew D. Galsky, Margaret Hoyle, Colombe Chappey, Ross Stewart, John A. Blake-Haskins, Timothy A. Yap

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Safety and Efficacy of Nivolumab in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study

    Safety and Efficacy of Nivolumab in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study 由 Nicholas J. Vogelzang, Mark R. Olsen, Joshua J. McFarlane, Edward Arrowsmith, Todd M. Bauer, Rohit Jain, Bradley G. Somer, Elaine T. Lam, Mark D. Kochenderfer, Ana M. Molina, Gurjyot K. Doshi, Brian M. Lingerfelt, Ralph J. Hauke, Vijay Gunuganti, Ian D. Schnadig, Peter J. Van Veldhuizen, Mark T. Fleming, Robert Galamaga, Mukul Kumar Gupta, Hugo Hool, Thomas Hutson, Joshua Zhang, M. Brent McHenry, Jennifer L. Johansen, Scott S. Tykodi

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: